Clinical Trial: BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess
Brief Summary: The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.
Detailed Summary:
Sponsor: Bayer
Current Primary Outcome: Adverse events occuring after first application of study medication up to the test of cure visit for non-serious adverse events [ Time Frame: Up to 30 days after end of treatment with study medication for serious adverse events ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Clinical Response [ Time Frame: Regulary doing i.v. treatment ]
Original Secondary Outcome: Same as current
Information By: Bayer
Dates:
Date Received: January 8, 2010
Date Started: February 2001
Date Completion:
Last Updated: January 8, 2010
Last Verified: January 2010